“…*Statistically significant compared to corresponding control at p < 0.001. potential, AA is a known neurotoxin (Tilson, 1981) and several occupationally exposed population studies have been reported to have an increased incidence of neurotoxicity syndromes (Deng et al, 1993) with typical symptoms of ataxia, skeletal muscle weakness, and weight loss (LoPachin, 2005). Similarly, neurotoxicity has also been reported in animal studies of AA-exposure, and is largely characterized by sensory, autonomic, and motor deficits due to nerve terminal dysfunction in the thalamus, basal ganglia, and other regions of the brain (Lehning et al, 2003;LoPachin, 2004LoPachin, , 2005Mehri et al, 2015). Indeed, we observed symptoms that resembled hind limb paralysis and sluggishness at 3 weeks of exposure to the high dose of AA; however, the symptoms associated with the likely neurotoxicity disappeared after cessation of AA-treatment and animals returned to phenotypic normal as soon as the AA treatment was stopped.…”